Adicet Bio
ACET
48 hedge funds and large institutions have $189M invested in Adicet Bio in 2019 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 16 increasing their positions, 13 reducing their positions, and 9 closing their positions.
48% more capital invested
Capital invested by funds: $128M → $189M (+$60.8M)
23% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 13
11% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 9
0.01% less ownership
Funds ownership: 0.47% → 0.46% (-0.01%)
2% less funds holding
Funds holding: 49 → 48 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
+$35M |
| 2 |
BlackRock
New York
|
+$4.72M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.13M |
| 4 |
RL
Ruffer LLP
London,
United Kingdom
|
+$952K |
| 5 |
State Street
Boston,
Massachusetts
|
+$886K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DAM
Deltec Asset Management
New York
|
-$2.86M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$2.85M |
| 3 |
SCM
Segantii Capital Management
Hong Kong
|
-$1.91M |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$1.02M |
| 5 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$1.02M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
MWNA
51
Marshall Wace North America
New York
| – | -$212K | -278 | Closed |
|
|
PCM
52
Pentwater Capital Management
Naples,
Florida
| – | -$177K | -232 | Closed |
|
53
Jane Street
New York
| – | -$117K | -154 | Closed |
|
|
SWM
54
SeaCrest Wealth Management
Purchase,
New York
| – | -$67K | -87 | Closed |
|
|
TRCT
55
Tower Research Capital (TRC)
New York
| – | -$46K | -61 | Closed |
|
56
Marshall Wace
London,
United Kingdom
| – | -$21K | -28 | Closed |
|
|
SO
57
STRS Ohio
Columbus,
Ohio
| – | -$12K | -17 | Closed |
|
ACET Hedge Fund Activity: Q2 2019 in Review
48 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in Adicet Bio (ACET) for Q2 2019, worth a combined $189M — up 48% from $128M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new ACET positions and 9 closed out — a net gain of 1 holder — while 16 added to existing stakes and 13 trimmed.
The largest buyer was Invesco, opening a new position worth an estimated $35M. The largest seller was Deltec Asset Management, cutting an estimated $2.86M.
- 48 institutional investors held Adicet Bio (ACET) as of Q2 2019, down from 49 in Q1 2019.
- Funds reported $189M of Adicet Bio stock for Q2 2019, up 48% quarter-over-quarter.
- 10 funds opened new Adicet Bio positions in Q2 2019 and 9 closed out, a net change of +1 holder.
- The largest Adicet Bio buyer in Q2 2019 was Invesco, an estimated $35M added.
- The largest Adicet Bio seller in Q2 2019 was Deltec Asset Management, an estimated $2.86M sold.
Based on aggregated 13F filings for Q2 2019.